Home > National Drug Code (NDC) > Triple Antibiotic

Triple Antibiotic - 51672-2016-2 - (Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate)

Alphabetical Index


Drug Information of Triple Antibiotic

Product NDC: 51672-2016
Proprietary Name: Triple Antibiotic
Non Proprietary Name: Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate
Active Ingredient(s): 400; 3.5; 5000    [iU]/g; mg/g; [iU]/g & nbsp;   Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate
Administration Route(s): TOPICAL
Dosage Form(s): OINTMENT
Coding System: National Drug Codes(NDC)

Labeler Information of Triple Antibiotic

Product NDC: 51672-2016
Labeler Name: Taro Pharmaceuticals U.S.A., Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part333B
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 19951214

Package Information of Triple Antibiotic

Package NDC: 51672-2016-2
Package Description: 1 TUBE in 1 CARTON (51672-2016-2) > 28.4 g in 1 TUBE

NDC Information of Triple Antibiotic

NDC Code 51672-2016-2
Proprietary Name Triple Antibiotic
Package Description 1 TUBE in 1 CARTON (51672-2016-2) > 28.4 g in 1 TUBE
Product NDC 51672-2016
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate
Dosage Form Name OINTMENT
Route Name TOPICAL
Start Marketing Date 19951214
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Taro Pharmaceuticals U.S.A., Inc.
Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength Number 400; 3.5; 5000
Strength Unit [iU]/g; mg/g; [iU]/g
Pharmaceutical Classes

Complete Information of Triple Antibiotic


General Information